|
|
Bone marrow suppression - Wikipedia, the free encyclopedia
Bone marrow suppression or myelotoxicity (adjective myelotoxic ) is a serious side-effect of chemotherapy and certain drugs affecting the immune system such as azathioprine. The risk is especiall...
en.wikipedia.org/wiki/Bone_marrow_suppression |
|
|
|
|
|
Myelosuppression is a common side effect from chemotherapy. What is myelosuppression? ... Myelosuppression is a decrease in the ability of the bone marrow to produce blood cells. Myelosuppression occurs most commmonly in lung cancer as a side effect of chemotherapy.
|
|
|
This early myelosuppression is managed with a temporary treatment interruption if there is grade 3 or greater neutropenia (absolute neutrophil count <1 x 109/L) or thrombocytopenia (platelets <50 x 109/L). Upon recovery, the tyrosine kinase is restarted at the same dose if counts recover within 2 weeks or at a lower dose...
|
|
|
A condition in which bone marrow activity is decreased, resulting in fewer red blood cells, white blood cells, and platelets. Myelosuppression is a side effect of some cancer treatments. (references)
|
|
|
myelosuppression - FastHealth Medical Dictionary ... Dictionary FastHealth Email This!; ... FastHealth Corporation (Tuscaloosa, Alabama - Tuscaloosa County);
|
|
|
In order to design an overall treatment plan and individualized CT schedules, ... Taking into account that a cytotoxicity mechanism of the majority of the chemotherapeutic drugs is due to their pharmacokinetics and pharmacodynamics and is involved in the damage to DNA structure, we have tried ... In the end of the treatment course,
|
Copyright © 2009, Dictionary.com, LLC. All rights reserved.